Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Assets (2016 - 2025)

Historic Assets for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q3 2025 value amounting to $1.4 billion.

  • Agios Pharmaceuticals' Assets fell 2266.38% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 2266.38%. This contributed to the annual value of $1.7 billion for FY2024, which is 7748.02% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Assets of $1.4 billion as of Q3 2025, which was down 2266.38% from $1.5 billion recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Assets high stood at $2.5 billion for Q1 2021, and its period low was $773.1 million during Q2 2024.
  • Moreover, its 5-year median value for Assets was $1.3 billion (2022), whereas its average is $1.4 billion.
  • Per our database at Business Quant, Agios Pharmaceuticals' Assets soared by 21115.62% in 2021 and then crashed by 4631.73% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Assets (Quarter) stood at $1.4 billion in 2021, then fell by 13.84% to $1.2 billion in 2022, then dropped by 24.35% to $937.1 million in 2023, then soared by 77.48% to $1.7 billion in 2024, then decreased by 16.68% to $1.4 billion in 2025.
  • Its Assets stands at $1.4 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.6 billion for Q1 2025.